Literature DB >> 23087047

Benign breast disease and the risk of subsequent breast cancer in African American women.

Michele L Cote1, Julie J Ruterbusch, Barra Alosh, Sudeshna Bandyopadhyay, Elizabeth Kim, Bassam Albashiti, Bashar Sharaf Aldeen, Derek C Radisky, Marlene H Frost, Daniel W Visscher, Lynn C Hartmann, Warzecha Hind Nassar, Rouba Ali-Femhi.   

Abstract

Benign breast disease (BBD) is an established risk factor for breast cancer among Caucasian women but less is known about BBD in African American women. As African American women suffer from disproportionate mortality due to breast cancer, special focus on pathologic characteristics that may influence disease risk is warranted. Benign breast biopsies from African American women were identified by the University Pathology Group (Detroit, MI). African American women of ages 20 to 84 years, who underwent a breast biopsy from 1997 to 2000, were eligible for the study. Subsequent breast cancers were identified through a linkage with the Detroit Surveillance Epidemiology and End Results (SEER) program. The first biopsy was reviewed by the pathologist, and lesions were classified following Dupont and Page criteria along with involution and other histologic features. Logistic regression was used to estimate the risk of developing a subsequent breast cancer with the histologic characteristics of BBD. A total of 1,406 BBD biopsies from African American women were included in this study with a median follow-up of 10.1 years. The majority (68%) showed nonproliferative disease, 29% had proliferative disease without atypia, and 3% had proliferative disease with atypia. Subsequent incident breast cancers occurred in 55 women (3.9%). Women whose biopsies showed proliferative disease with atypia were more than three-fold more likely to develop breast cancer as compared with women who had nonproliferative disease [relative risk (RR) 3.29, 95% confidence interval (CI) 1.21-8.93]. Better characterization of the risk of breast cancer among women with BBD, considering both ethnicity and detailed molecular findings, can lead to better surveillance, earlier diagnosis, and potentially improved survival. ©2012 AACR

Entities:  

Mesh:

Year:  2012        PMID: 23087047      PMCID: PMC3518609          DOI: 10.1158/1940-6207.CAPR-12-0175

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  19 in total

1.  Age-related lobular involution and risk of breast cancer.

Authors:  Tia R Milanese; Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Amy C Degnim; Celine M Vachon; Carol A Reynolds; Romayne A Thompson; L Joseph Melton; Ellen L Goode; Daniel W Visscher
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

2.  Management of complex breast cysts.

Authors:  L A Venta; J P Kim; C E Pelloski; M Morrow
Journal:  AJR Am J Roentgenol       Date:  1999-11       Impact factor: 3.959

3.  Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.

Authors:  L M Marshall; D J Hunter; J L Connolly; S J Schnitt; C Byrne; S J London; G A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-05       Impact factor: 4.254

Review 4.  On the possible role of involution in the natural history of breast cancer.

Authors:  D E Henson; R E Tarone
Journal:  Cancer       Date:  1993-03-15       Impact factor: 6.860

5.  Benign breast disease. Resolved and unresolved issues.

Authors:  J L Connolly; S J Schnitt
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

6.  Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.

Authors:  Julie R Palmer; Deborah A Boggs; Lauren A Wise; Christine B Ambrosone; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-16       Impact factor: 4.254

7.  Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.

Authors:  Maria J Worsham; Judith Abrams; Usha Raju; Alissa Kapke; Mei Lu; Jingfang Cheng; Donna Mott; Sandra R Wolman
Journal:  Breast J       Date:  2007 Mar-Apr       Impact factor: 2.431

8.  Benign breast disease and the risk of breast cancer.

Authors:  Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Wilma L Lingle; Amy C Degnim; Karthik Ghosh; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; David W Hillman; Vera J Suman; Jo Johnson; Cassann Blake; Thea Tlsty; Celine M Vachon; L Joseph Melton; Daniel W Visscher
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

Review 9.  Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.

Authors:  W D Dupont; F F Parl; W H Hartmann; L A Brinton; A C Winfield; J A Worrell; P A Schuyler; W D Plummer
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

10.  Projecting individualized absolute invasive breast cancer risk in African American women.

Authors:  Mitchell H Gail; Joseph P Costantino; David Pee; Melissa Bondy; Lisa Newman; Mano Selvan; Garnet L Anderson; Kathleen E Malone; Polly A Marchbanks; Worta McCaskill-Stevens; Sandra A Norman; Michael S Simon; Robert Spirtas; Giske Ursin; Leslie Bernstein
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

View more
  10 in total

1.  Acupuncture for mammary gland hyperplasia: A Bayesian network meta-analysis protocol.

Authors:  Jun Xiong; Honglian Li; Fanghui Hua; Shouqiang Huang; Jie Xiang; Yunfeng Jiang; Kai Liao; Xiaohong Zhou; Meihua Liu
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

2.  Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Authors:  Susanna D Mitro; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay; Baraa Alosh; Bassam Albashiti; Derek C Radisky; Marlene H Frost; Amy C Degnim; Julie J Ruterbusch; Michele L Cote
Journal:  Breast J       Date:  2014-09-08       Impact factor: 2.431

3.  Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.

Authors:  Lisa A Newman; Azadeh Stark; Dhanajay Chitale; Margaret Pepe; Gary Longton; Maria J Worsham; S David Nathanson; Patricia Miller; Jessica M Bensenhaver; Erica Proctor; Monique Swain; Christos Patriotis; Paul F Engstrom
Journal:  JAMA Oncol       Date:  2017-08-01       Impact factor: 31.777

4.  Benign proliferative breast diseases among female patients at a sub-Saharan Africa tertiary hospital: a cross sectional study.

Authors:  Christopher Okoth; Moses Galukande; Josephat Jombwe; Dan Wamala
Journal:  BMC Surg       Date:  2013-04-01       Impact factor: 2.102

5.  Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast.

Authors:  Chelsea Catsburg; Marc J Gunter; Lesley Tinker; Rowan T Chlebowski; Michael Pollak; Howard D Strickler; Michele L Cote; David L Page; Thomas E Rohan
Journal:  J Cancer Epidemiol       Date:  2015-05-28

6.  Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.

Authors:  Xavier Castells; Laia Domingo; Josep María Corominas; Isabel Torá-Rocamora; María Jesús Quintana; Marisa Baré; Carmen Vidal; Carmen Natal; Mar Sánchez; Francina Saladié; Joana Ferrer; Mar Vernet; Sonia Servitja; Ana Rodríguez-Arana; Marta Roman; Josep Alfons Espinàs; María Sala
Journal:  Breast Cancer Res Treat       Date:  2014-12-13       Impact factor: 4.872

7.  Subtypes of Benign Breast Disease as a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis Protocol.

Authors:  Manoosh Zendehdel; Babak Niakan; Abbasali Keshtkar; Elahe Rafiei; Fatemeh Salamat
Journal:  Iran J Med Sci       Date:  2018-01

8.  Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Authors:  Asra N Shaik; Julie J Ruterbusch; Eman Abdulfatah; Resha Shrestha; M H D Fayez Daaboul; Visakha Pardeshi; Daniel W Visscher; Sudeshna Bandyopadhyay; Rouba Ali-Fehmi; Michele L Cote
Journal:  Breast Cancer Res       Date:  2018-08-09       Impact factor: 6.466

9.  A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria.

Authors:  Stella O Odedina; IkeOluwapo O Ajayi; Adenike Adeniji-Sofoluwe; Imran O Morhason-Bello; Dezheng Huo; Olufunmilayo I Olopade; Oladosu A Ojengbede
Journal:  BMC Womens Health       Date:  2018-09-19       Impact factor: 2.809

Review 10.  Subtypes of Benign Breast Disease as a Risk Factor of Breast Cancer: A Systematic Review and Meta Analyses.

Authors:  Fatemeh Salamat; Babak Niakan; Abbasali Keshtkar; Elahe Rafiei; Manoosh Zendehdel
Journal:  Iran J Med Sci       Date:  2018-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.